Patents Assigned to Elorac, Ltd.
  • Publication number: 20130079312
    Abstract: Methods and composition for preventing and/or treating hair loss associated with the administration of cancer chemotherapy using vasoconstrictors are disclosed. Optionally corticosteroids are also in the formulation.
    Type: Application
    Filed: September 28, 2011
    Publication date: March 28, 2013
    Applicant: ELORAC, LTD.
    Inventor: Joel E. Bernstein
  • Publication number: 20120041015
    Abstract: Methods and compositions are described for the treatment of very severe acne vulgaris, including nodulocystic acne and conglobate acne. Compounds which inhibit either or both type 1 and type 2 isoforms of steroid 5?-reductase are administered daily in either oral or topical formulations to patients suffering from severe forms of acne vulgaris. Very high dosages of such compounds can effectively be administered oral just once a week and be successful.
    Type: Application
    Filed: August 10, 2010
    Publication date: February 16, 2012
    Applicant: ELORAC, LTD.
    Inventor: Joel E. Bernstein
  • Patent number: 4505896
    Abstract: An improved method of treating acne vulgaris comprising administering a therapeutically effective amount of nicotinic acid or nicotinamide and compositions useful in said method.
    Type: Grant
    Filed: November 24, 1980
    Date of Patent: March 19, 1985
    Assignee: Elorac, Ltd.
    Inventor: Joel E. Bernstein